2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2016-2-4-95-100942Archive categoriesAPPLICATION OF DIFFERENT THICKENER-PROLONGATORS OF THE KOLLIDON GRADES IN THE PHARMACEUTICAL TECHNOLOGYAPPLICATION OF DIFFERENT THICKENER-PROLONGATORS OF THE KOLLIDON GRADES IN THE PHARMACEUTICAL TECHNOLOGYZhilyakovaElena T.ZhilyakovaElena T.ezhilyakova@bsu.edu.ruAgarinaAleksandra V.AgarinaAleksandra V.NovikovaMarina Yu.NovikovaMarina Yu.mnovikova@bsu.edu.ruIvanovaLarisa L.IvanovaLarisa L.20162400

The article provides an overview and comparative characteristics of various polyvinylpyrrolidone grades, widely used in modern industrial production of drugs. It was found that the main characteristics of this group of adjuvants is the ability to influence the solubility of the active ingredients and their release, to act as disintegrants, binders, film formers and fillers to reduce the irritant effect of certain substances (in contact with mucous membranes), to provide thickening and prolongation of a part of ophthalmic formulations. One of the major manufacturers of Kollidon is a German company BASF, which produces insoluble polyvinylpyrrolidone grades (Kollidon CL, Kollidon CL-M, Kollidon SR), and water-soluble (Kollidon 12 PF, Kollidon 17 PF, Kollidon 25, Kollidon 30, Kollidon 90 F , Kollidon VA 64). Owing to their wide range of properties, Kollidons are used in most dosage forms, preferably tablets (including in the coating composition), eye drops and gels.

The article provides an overview and comparative characteristics of various polyvinylpyrrolidone grades, widely used in modern industrial production of drugs. It was found that the main characteristics of this group of adjuvants is the ability to influence the solubility of the active ingredients and their release, to act as disintegrants, binders, film formers and fillers to reduce the irritant effect of certain substances (in contact with mucous membranes), to provide thickening and prolongation of a part of ophthalmic formulations. One of the major manufacturers of Kollidon is a German company BASF, which produces insoluble polyvinylpyrrolidone grades (Kollidon CL, Kollidon CL-M, Kollidon SR), and water-soluble (Kollidon 12 PF, Kollidon 17 PF, Kollidon 25, Kollidon 30, Kollidon 90 F , Kollidon VA 64). Owing to their wide range of properties, Kollidons are used in most dosage forms, preferably tablets (including in the coating composition), eye drops and gels.

polyvinylpyrrolidonesKollidonexcipientspharmaceutical technologypolyvinylpyrrolidonesKollidonexcipientspharmaceutical technologyСписок литературыEgoshina Ju.A., Potselueva L.A. Modern excipients in tablet production. The success of modern science. 2009. № 10. Pp. 11-14.Zhilyakova E.T., Baskakova, A.V., Novikova M.Yu. Development of technological methods to enhance the solubility of acyclovir. Fundamental research. 2013. № 6. Pp. 646-650.Likhoded V.A., Marvanova A.V., Pupykina K.A. On the possibility of using the novel excipient Kollidon CL-M technology in dental sticks containing phytopreparation. Medical bulletin of Bashkortostan. 2010. № 2. Pp. 94-96.Ahmed H. Elshafeey, Elshaimaa Sami I. Preparation and In-vivo Pharmacokinetic Study of a Novel Extended Release Compression Coated Tablets of Fenoterol Hydrobromide. Pharmaceutical Science Technology. 2008 Vol. 9, №3. Pp. 1016-1024.Buhler V. Kollidon - polyvinylpyrrolidone excipients for the pharmaceutical industry. 9th Ed. Ludwigshafen: BASF SE, 2008. 330 p.De Mello Costa A. R., Marquiafavel F.S. Quercetin-PVP K25 solid dispersions. Journal of Thermal Analysis and Calorimetry. 2011. Vol. 104. № 1. Pp. 273-278.Hosono T., Tsuchiya S., Matsumary H. Formation of complex compound with PVP. Journal of  Pharmaceutical Scienses. 2008. Vol. 7, № 2. Pp. 824-826.Kasperek R., Zimmer L. The application of povidone in the preparation of modified release tablets. Current Issues in Pharmacy and Medical Sciences. 2016. Vol. 29, № 2. Pp.71-78.Nurnberg E. Using of different excipients in direct compression. Pharmaceutical Industry. 2006. Vol. 5, № 1. Pp. 291-304.Sahoo J., Murthy P., Biswal S. Formulation of Sustained-Release Dosage Form of Verapamil Hydrochloride by Solid Dispersion Technique Using Eudragit RLPO or Kollidon SR. Pharmaceutical Science Technology. 2009. Vol. 10, № 1. Pp. 27-33.Tres F., Treacher K. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release. Molecular Pharmaceutics. 2016. Vol. 13, № 3. Pp. 50-56.